These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34322239)

  • 1. Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide.
    Hashimoto A; Tanaka Y; Shinzato I
    Clin Case Rep; 2021 Jul; 9(7):e04300. PubMed ID: 34322239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide.
    Hashimoto A; Tanaka Y; Ishikawa T; Shinzato I
    Clin Case Rep; 2021 Jul; 9(7):e04417. PubMed ID: 34322242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of relapsed acute promyelocytic leukemia with arsenic trioxide in a hemodialysis-dependent patient: A case report.
    Lee HJ; Park SG
    World J Clin Cases; 2020 Nov; 8(21):5347-5352. PubMed ID: 33269269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report.
    Emmons GS; Steingart RH; Stewart JA; Mertens WC
    J Med Case Rep; 2012 Oct; 6():355. PubMed ID: 23078653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis.
    Tinajero J; El-Shami K; Wu X; Smith BD; Newman MJ
    Leuk Res Rep; 2022; 17():100304. PubMed ID: 35371914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
    Leu L; Mohassel L
    Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
    Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
    Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide.
    Hirayama Y; Koyama R; Nagai T; Ohta H; Kondo A; Ishikawa K; Ishitani K; Matsunaga T; Sakamaki S; Niitsu Y
    Intern Med; 2001 Nov; 40(11):1136-9. PubMed ID: 11757771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
    Kutny MA; Alonzo TA; Abla O; Rajpurkar M; Gerbing RB; Wang YC; Hirsch BA; Raimondi S; Kahwash S; Hardy KK; Hardy S; Meshinchi S; Gamis AS; Kolb EA; Feusner JH; Gregory J
    JAMA Oncol; 2022 Jan; 8(1):79-87. PubMed ID: 34762093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.
    Perreault S; Moeller J; Patel K; Eyler R; Pham T; Russell K; Podoltsev N
    J Oncol Pharm Pract; 2016 Aug; 22(4):646-51. PubMed ID: 25972392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
    Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
    Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy.
    Ghavamzadeh A; Alimoghaddam K; Ghaffari SH; Rostami S; Jahani M; Hosseini R; Mossavi A; Baybordi E; Khodabadeh A; Iravani M; Bahar B; Mortazavi Y; Totonchi M; Aghdami N
    Ann Oncol; 2006 Jan; 17(1):131-4. PubMed ID: 16227315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure, gastrointestinal bleeding, and cardiac arrhythmia after administration of arsenic trioxide for acute promyelocytic leukemia.
    Cashin R; Burry L; Peckham K; Reynolds S; Seki JT
    Am J Health Syst Pharm; 2008 May; 65(10):941-6. PubMed ID: 18463343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.
    Ghavamzadeh A; Alimoghaddam K; Rostami S; Ghaffari SH; Jahani M; Iravani M; Mousavi SA; Bahar B; Jalili M
    J Clin Oncol; 2011 Jul; 29(20):2753-7. PubMed ID: 21646615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
    Sasijareonrat N; Jahn N; Ungprasert P; Owattanapanich W
    Technol Cancer Res Treat; 2020; 19():1533033820937008. PubMed ID: 32583728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment With ATRA and Arsenic Trioxide for a Child With Down Syndrome and Acute Promyelocytic Leukemia.
    Tsumura Y; Yamada Y; Osumi T; Kato M; Terashima K; Shioda Y; Kiyotani C; Matsumoto K; Tomizawa D
    J Pediatr Hematol Oncol; 2020 May; 42(4):322-325. PubMed ID: 30807394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-adjusted arsenic trioxide for acute promyelocytic leukaemia in chronic renal failure.
    Firkin F; Roncolato F; Ho WK
    Eur J Haematol; 2015 Oct; 95(4):331-5. PubMed ID: 25600167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular repolarization dynamics in arsenic trioxide treatment of acute promyelocytic leukemia.
    Sun Y; Wang L; Que Y; Zhu H; Yang X; Li D
    Int J Cardiol; 2020 May; 306():163-167. PubMed ID: 31761398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia - A retrospective clinical study.
    Ge F; Zhang Y; Cao F; Li J; Hou J; Wang P; Li H; Xu M; Liu S; Li L; Li X; Wang S; Lv C; Su Y; Zhou J
    Hematology; 2016 Jun; 21(5):287-94. PubMed ID: 26871996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia.
    Alimoghaddam K; Shariftabrizi A; Tavangar SM; Sanaat Z; Rostami S; Jahani M; Ghavamzadeh A
    Leuk Lymphoma; 2006 Jan; 47(1):81-8. PubMed ID: 16321832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.